Trial intelligence / Profile preview

Buprenorphine/Naloxone vs Methadone for Opioid Dependence

NCT00000328Phase 2Withdrawn

Sponsor
University of Colorado Denver
Start
Jul 1997
Primary completion
Aug 1997
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of buprenorphine, naloxone in opioid use disorder (OUD), sponsored by University of Colorado Denver. Planned start Jul 1997; status: withdrawn.

02

Drugs

buprenorphinenaloxone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00000328.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000328.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call